Bruce Carlson

Business Insights
Romanian IVD market worth watching, rose to $464M in 2022
The Eastern European country's IVD market will grow 25% faster than that of the United States, according to Kalorama Information in its latest 30-Country IVD Market Atlas.
May 31, 2023
Business Financial Results Social
Business Insights
U.K. IVD market grows to $4.6 billion; Brexit not a factor
The U.K. market is expected to grow just under 3% per year for the next five years, the report said, faster than Italy, France, or the Netherlands, and at about the same rate as Germany.
May 4, 2023
Business Deal Corporate Social
Business Insights
Declining COVID-19 test market may still reach $25M in 2023: Report
Despite a decline in sales, COVID-19 is expected to represent one of the larger single-disease categories in IVD testing, according to Kalorama. Rapid testing, mostly antigen-based, will hold up the market while growth drops in lab-based PCR testing.
April 28, 2023
Coronavirus Business Graphic3 Social
Business Insights
Point-of-care IVD sales rose to $45 billion in 2022
Numerous trends will combine to enable a growing market. According to the Kalorama report, growth of 3.3% per year is expected over the forecast period from 2022 to 2027.
April 19, 2023
3d Closeup Coronavirus Social
Business Insights
Brazilian IVD market rises to $1.7B
The demand for clinical testing equipment in Brazil is partly driven by an aging population, Kalorama noted. People 65 and over are expected to account for 14.1% of the total population by 2032.
April 18, 2023
Financials Growth Revenue Business Social
Business Insights
Swedish IVD market estimated at $804 million in 2022: Kalorama Information
Critical care point-of-care tests, used for assessment of emergency room (ER) and intensive care unit (ICU) patients in hospitals or ambulatory settings, are expected to grow about three times faster in Sweden than in the U.S. over the next five years.
March 31, 2023
Business Financial Results Social
Business Insights
U.S. IVD market reaches $53 billion
According to Kalorama Information, the U.S. IVD market is projected to grow at a 2.4% average annual rate through 2027.
March 22, 2023
Business Intelligence Social
Business Insights
IVD physician office market was $8.3 billion in 2022: Kalorama
An increase in the number of diseases for which physician offices are often the first to test is influencing physician office lab IVD revenue growth.
January 23, 2023
Business Intelligence 400
Liquid Biopsy
$1.3 billion liquid biopsy market represents the present and future of clinical oncology: Kalorama
The liquid biopsy market can be segmented by the type of analyte detected and analyzed. There are four main categories: circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes and other analytes, and multiple analytes.
January 19, 2023
Lab Test Tube Dna Blood Social
Business Insights
Highly competitive molecular diagnostics market reaches $21B: Kalorama
The market largely consists of COVID-19 sales, but future growth in the market will be fueled by other applications, according to Kalorama Information.
November 8, 2022
Business Financial Results Social
Page 1 of 7
Next Page
Top Stories
Proscia Embeddings
Artificial Intelligence
Proscia launches pathology AI model toolkit
Proscia has launched Concentriq Embeddings for experimenting with multiple pathology artificial intelligence (AI) models in parallel.
Crispr Cas9 Gene Editing
Emerging Technology
CRISPR patent decisions could trigger waves globally
Doctor Patient Consult
Pathology and AI
Ibex survey indicates some comfort with AI in cancer diagnostics
Olfactory Bulb Brain Cr Social
Pathology and AI
Pathologists detect microplastics in human brain tissue
Body composition in patients treated with Ozempic
Sponsor Content
Body composition in patients treated with Ozempic
More in Home
Proscia launches pathology AI model toolkit
By Liz Carey
Proscia has launched Concentriq Embeddings for experimenting with multiple pathology artificial intelligence (AI) models in parallel.
October 2, 2024
Proscia Embeddings
CRISPR patent decisions could trigger waves globally
By LabPulse.com staff writers
Canceling a pair of patents in Europe will affect a broad network of biotech companies that have bought and sold the rights to pursue gene-slicing research, according to a September 25 report published in MIT Technology Review.
September 30, 2024
Crispr Cas9 Gene Editing
Ibex survey indicates some comfort with AI in cancer diagnostics
By LabPulse.com staff writers
A recent survey reports that more than 50% of U.S. adults have received an incorrect medical test result for themselves or a loved one. Additionally, 60% would trust artificial intelligence (AI) supporting medical diagnoses.
September 25, 2024
Doctor Patient Consult
Pathologists detect microplastics in human brain tissue
By Will Morton
Pathologists have detected microplastics in the olfactory bulb brain tissues of eight deceased individuals in Sao Paulo, highlighting the need for further research about their effects on human health, reports a study published in JAMA Network Open.
September 25, 2024
Olfactory Bulb Brain Cr Social
NIH establishes pandemic preparedness research network
By LabPulse.com staff writers
The U.S. National Institutes of Health (NIH) has established a pandemic preparedness research network for research on the pathogens that are most likely to threaten human health.
September 19, 2024
Infectious Diseases Research Social
CDC adds commercial lab contracts for infectious disease, bird flu testing
By Liz Carey
Clinical laboratories incentivized to develop diagnostic tests earlier.
September 17, 2024
Colorized transmission electron micrograph of avian influenza A H5N1 virus particles shown in yellow.
Multiregional clinical trial data on FDA watch for U.S. applicability
By LabPulse.com staff writers
Pivotal trials drawing on foreign clinical data in focus.
September 16, 2024
Fda Sign Dc Social
Seegene launches 3rd RUO mpox assay
By LabPulse.com staff writers
After introducing two research use only (RUO) mpox assays in August, Seegene has expanded its mpox assay line with a third RUO assay designed to address the spread of the mpox virus variant clade Ib currently prevalent in the mpox outbreak in Africa.
September 10, 2024
3 D Monkeypox Infecting Cell Social
Hospital labs targeted in proposed Calif. hospital licensing regulations
By Liz Carey
Proposed changes could require some hospitals to materially alter their current operations, according to advisers.
September 11, 2024
Regulation Wheel Social
HudsonAlpha Institute gets $2.9M NIH grant for pediatric rare disease sequencing
By LabPulse.com staff writers
Scientists at the HudsonAlpha Institute for Biotechnology in Huntsville, AL, have been awarded a five-year, $2.9 million U.S. National Institutes of Health (NIH) grant to identify genetic contributors to rare diseases in children.
September 6, 2024
Dna Sequencing Data Analysis Social
ADLM releases guidance for blood lipid assessment, lipoprotein testing
By LabPulse.com staff writers
Document outlines recommendations for standardizing clinical lipid testing workflows.
September 4, 2024
Blood Test Samples Lab Social
Seegene, Springer Nature launch PCR innovation program
By LabPulse.com staff writers
Molecular diagnostics firm Seegene and Springer Nature have launched a new project for the development of diagnostic assays, as part of their ongoing strategic partnership.
September 3, 2024
Research Money Social
Page 1 of 125
Next Page